HK1178887A1 - 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25- - Google Patents
2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25-Info
- Publication number
- HK1178887A1 HK1178887A1 HK13105593.5A HK13105593A HK1178887A1 HK 1178887 A1 HK1178887 A1 HK 1178887A1 HK 13105593 A HK13105593 A HK 13105593A HK 1178887 A1 HK1178887 A1 HK 1178887A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- edg
- agonists
- derivatives
- substituted oxazolopyrimidine
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10305044 | 2010-01-14 | ||
PCT/EP2011/050303 WO2011086081A1 (de) | 2010-01-14 | 2011-01-12 | 2,5-substituierte oxazolopyrimidinderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1178887A1 true HK1178887A1 (en) | 2013-09-19 |
Family
ID=41800382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13105593.5A HK1178887A1 (en) | 2010-01-14 | 2013-05-10 | 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25- |
Country Status (21)
Country | Link |
---|---|
US (1) | US9040544B2 (ja) |
EP (1) | EP2523963B1 (ja) |
JP (1) | JP5841069B2 (ja) |
KR (1) | KR101764607B1 (ja) |
CN (1) | CN102834400B (ja) |
AR (1) | AR079885A1 (ja) |
AU (1) | AU2011206617B2 (ja) |
BR (1) | BR112012017484A2 (ja) |
CA (1) | CA2784565C (ja) |
DK (1) | DK2523963T3 (ja) |
ES (1) | ES2524712T3 (ja) |
HK (1) | HK1178887A1 (ja) |
IL (1) | IL220719A (ja) |
MX (1) | MX2012007837A (ja) |
MY (1) | MY159857A (ja) |
PT (1) | PT2523963E (ja) |
RU (1) | RU2554874C2 (ja) |
SG (1) | SG182483A1 (ja) |
TW (1) | TWI544926B (ja) |
UY (1) | UY33181A (ja) |
WO (1) | WO2011086081A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR079980A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
AR079981A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido |
AU2011206616B2 (en) * | 2010-01-14 | 2016-06-16 | Sanofi | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
MX2012007834A (es) * | 2010-01-14 | 2012-07-30 | Sanofi Sa | Derivados de acido carboxilico que comprenden un anillo de oxazolopirimidina 2,5-sustituido. |
US9321787B2 (en) | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
MXPA05010802A (es) * | 2003-04-25 | 2005-12-14 | Univ Cardiff | Compuestos heterociclicos para el uso en el tratamiento de infecciones virales. |
AU2004234067B2 (en) * | 2003-04-30 | 2008-02-28 | Novartis Ag | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
MXPA05012461A (es) * | 2003-05-19 | 2006-02-22 | Irm Llc | Compuestos y composiciones inmunosupresores. |
BRPI0615133A2 (pt) * | 2005-08-23 | 2011-05-03 | Irm Llc | compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso |
EP1965807A4 (en) | 2005-11-23 | 2010-10-27 | Epix Delaware Inc | S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE |
US7919519B2 (en) * | 2005-11-23 | 2011-04-05 | Epix Pharmaceuticals Inc. | S1P receptor modulating compounds and use thereof |
EP2364976B1 (en) * | 2007-03-21 | 2014-10-08 | EPIX Pharmaceuticals, Inc. | S1P receptor modulating compounds and use thereof |
WO2009013545A2 (en) * | 2007-07-26 | 2009-01-29 | Astrazeneca Ab | Chemical compounds |
US7863291B2 (en) * | 2008-04-23 | 2011-01-04 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
EP2318415B1 (en) * | 2008-07-15 | 2013-02-20 | Sanofi | Oxazolopyrimidines as edg-1 receptor agonists |
AR079981A1 (es) * | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido |
UY33178A (es) | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
AR079980A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
MX2012007834A (es) | 2010-01-14 | 2012-07-30 | Sanofi Sa | Derivados de acido carboxilico que comprenden un anillo de oxazolopirimidina 2,5-sustituido. |
AU2011206616B2 (en) * | 2010-01-14 | 2016-06-16 | Sanofi | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
-
2011
- 2011-01-12 ES ES11700529.8T patent/ES2524712T3/es active Active
- 2011-01-12 CA CA2784565A patent/CA2784565C/en not_active Expired - Fee Related
- 2011-01-12 SG SG2012051397A patent/SG182483A1/en unknown
- 2011-01-12 EP EP11700529.8A patent/EP2523963B1/de active Active
- 2011-01-12 TW TW100101051A patent/TWI544926B/zh not_active IP Right Cessation
- 2011-01-12 BR BR112012017484-3A patent/BR112012017484A2/pt active Search and Examination
- 2011-01-12 AR ARP110100094A patent/AR079885A1/es active IP Right Grant
- 2011-01-12 MX MX2012007837A patent/MX2012007837A/es active IP Right Grant
- 2011-01-12 CN CN201180014162.5A patent/CN102834400B/zh active Active
- 2011-01-12 PT PT117005298T patent/PT2523963E/pt unknown
- 2011-01-12 WO PCT/EP2011/050303 patent/WO2011086081A1/de active Application Filing
- 2011-01-12 MY MYPI2012002622A patent/MY159857A/en unknown
- 2011-01-12 KR KR1020127021237A patent/KR101764607B1/ko active IP Right Grant
- 2011-01-12 RU RU2012134636/04A patent/RU2554874C2/ru active
- 2011-01-12 UY UY0001033181A patent/UY33181A/es not_active Application Discontinuation
- 2011-01-12 DK DK11700529.8T patent/DK2523963T3/en active
- 2011-01-12 JP JP2012548412A patent/JP5841069B2/ja active Active
- 2011-01-12 AU AU2011206617A patent/AU2011206617B2/en not_active Ceased
- 2011-01-14 US US13/521,825 patent/US9040544B2/en active Active
-
2012
- 2012-07-02 IL IL220719A patent/IL220719A/en active IP Right Grant
-
2013
- 2013-05-10 HK HK13105593.5A patent/HK1178887A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL220719A (en) | 2015-03-31 |
AR079885A1 (es) | 2012-02-29 |
CA2784565C (en) | 2018-03-13 |
EP2523963A1 (de) | 2012-11-21 |
MX2012007837A (es) | 2012-07-30 |
ES2524712T3 (es) | 2014-12-11 |
KR20120115403A (ko) | 2012-10-17 |
PT2523963E (pt) | 2014-11-06 |
CA2784565A1 (en) | 2011-07-21 |
SG182483A1 (en) | 2012-08-30 |
EP2523963B1 (de) | 2014-08-27 |
TWI544926B (zh) | 2016-08-11 |
US20130072501A1 (en) | 2013-03-21 |
AU2011206617A1 (en) | 2012-08-02 |
RU2012134636A (ru) | 2014-02-20 |
UY33181A (es) | 2011-08-31 |
JP5841069B2 (ja) | 2016-01-06 |
BR112012017484A2 (pt) | 2020-08-25 |
JP2013517243A (ja) | 2013-05-16 |
US9040544B2 (en) | 2015-05-26 |
DK2523963T3 (en) | 2014-12-01 |
CN102834400B (zh) | 2015-06-10 |
CN102834400A (zh) | 2012-12-19 |
KR101764607B1 (ko) | 2017-08-03 |
MY159857A (en) | 2017-02-15 |
TW201134473A (en) | 2011-10-16 |
RU2554874C2 (ru) | 2015-06-27 |
AU2011206617B2 (en) | 2015-07-16 |
WO2011086081A1 (de) | 2011-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201206440B (en) | [5,6]heterocyclic compound | |
ZA201205788B (en) | 1,2,4-triazine-4-amine derivatives | |
PL2590916T3 (pl) | Trwała kompozycja 2,3,3,3-tetrafluoropropenu | |
EP2520575A4 (en) | 1,3,4-OXADIAZOLE-2-CARBOXAMIDE COMPOUND | |
PT2588556T (pt) | Composição contendo 2,3,3,3-tetrafluoropropeno | |
SI2384326T1 (sl) | Pirolo(2,3-d)pirimidinske spojine | |
EP2361902A4 (en) | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG | |
AP2010005364A0 (en) | Novel heterocyclic compounds. | |
EP2699091A4 (en) | 2 ', 6'-dioxo-3'-deutero-PIPERIDIN-3-YL-isoindoline COMPOUNDS | |
IL225785A0 (en) | Heterocyclic compounds, preparations containing them and their uses | |
PL2621903T3 (pl) | Związki n-heteroarylu | |
ZA201303116B (en) | Imine substituted 2,4-diaryl-pyrroline derivatives as pesticides | |
IL210639A0 (en) | Oxazolopyrimidines as edg-1 receptor agonists | |
PL2619278T3 (pl) | Kompozycja na bazie 3,3,3-trifluoropropenu | |
EP2606021A4 (en) | 1,5-diphenyl-penta-1,4-dien-3-one compounds | |
IL229712A (en) | The aryl sulfonamide compounds are converted into two positions 2 and 5 | |
HK1182109A1 (zh) | -三唑酮衍生物 | |
IL220707A0 (en) | 2,5,7-substituted oxazolopyrimidine derivatives | |
HK1178887A1 (en) | 2,5-substituted oxazolopyrimidine derivatives as edg-1 agonists edg-1 25- | |
IL214110A0 (en) | 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds | |
SI2266990T1 (sl) | Spojina 3-fenilpirazolo(5,1-b)tiazola | |
ZA201302249B (en) | Novel gpr 119 agonists | |
GB201011831D0 (en) | New compounds 5 | |
HK1162032A1 (en) | 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2- | |
IL212259A0 (en) | 5,5'-azotetrazolate explosive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220108 |